Pre-Mortem Histopathologic Evidence of Endothelial Injury and Thrombotic Microangiopathy in an Infant With SARS-CoV-2-Associated Multisystem Inflammatory Syndrome (MIS-C).

Publication date: Jun 22, 2026

Multisystem inflammatory syndrome in children (MIS-C) represents a severe postinfectious hyperinflammatory condition following SARS-CoV-2 infection. Despite extensive clinical characterization, histopathologic data-especially from pre-mortem pediatric biopsies-remain scarce. We report a 9-month-old male infant with confirmed SARS-CoV-2 infection and rapid multiorgan failure. Pre-mortem incisional biopsies from the myocardium, lung, and pleura revealed degenerative myocyte changes, endothelial swelling, and fibrin-platelet microthrombi consistent with thrombotic microangiopathy. Immunohistochemistry demonstrated mild CD3+ T-cell-predominant infiltrates and focal SARS-CoV-2 antigen positivity confined to alveolar and bronchiolar epithelium, while myocardial and pleural tissues were negative. These findings highlight early morphologic correlates of immune-mediated vascular injury in MIS-C, characterized by endothelial dysfunction, microvascular inflammation, and T-cell-driven immunopathology in the absence of direct viral cytopathy. This case provides rare pre-mortem evidence of immune-thrombotic endotheliopathy in an infant, bridging clinical and histologic manifestations of pediatric SARS-CoV-2-associated hyperinflammatory disease.

Concepts Keywords
Endotheliopathy Associated
Month Clinical
Pediatric Cov
Rare Endothelial
Viral Evidence
Histopathologic
Infant
Injury
Microangiopathy
Mis
Mortem
Pre
Sars
Thrombotic

Semantics

Type Source Name
disease MESH Injury
disease MESH Thrombotic Microangiopathy
disease MESH Syndrome
disease MESH Multisystem inflammatory syndrome in children
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH vascular injury
disease MESH inflammation

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *